rs770149373

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4BS2_Supporting

The NM_004006.3(DMD):​c.1604T>C​(p.Val535Ala) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000368 in 1,085,974 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V535I) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000037 ( 0 hom. 2 hem. )

Consequence

DMD
NM_004006.3 missense, splice_region

Scores

1
2
13
Splicing: ADA: 0.001136
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 3.52

Publications

0 publications found
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
DMD Gene-Disease associations (from GenCC):
  • Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • dilated cardiomyopathy 3B
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Duchenne and Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Duchenne muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • progressive muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.33693278).
BS2
High Hemizygotes in GnomAdExome4 at 2 XL,AD geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DMDNM_004006.3 linkc.1604T>C p.Val535Ala missense_variant, splice_region_variant Exon 14 of 79 ENST00000357033.9 NP_003997.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkc.1604T>C p.Val535Ala missense_variant, splice_region_variant Exon 14 of 79 1 NM_004006.3 ENSP00000354923.3

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD2 exomes
AF:
0.0000111
AC:
2
AN:
180752
AF XY:
0.0000153
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000368
AC:
4
AN:
1085974
Hom.:
0
Cov.:
29
AF XY:
0.00000569
AC XY:
2
AN XY:
351756
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26192
American (AMR)
AF:
0.00
AC:
0
AN:
35109
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19278
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30163
South Asian (SAS)
AF:
0.0000559
AC:
3
AN:
53658
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40466
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4114
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
831300
Other (OTH)
AF:
0.0000219
AC:
1
AN:
45694
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Uncertain:1
Aug 07, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Duchenne muscular dystrophy Uncertain:1
Aug 30, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine with alanine at codon 535 of the DMD protein (p.Val535Ala). The valine residue is moderately conserved and there is a small physicochemical difference between valine and alanine. This variant is present in population databases (rs770149373, ExAC 0.01%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with DMD-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.061
T
BayesDel_noAF
Benign
-0.11
CADD
Benign
16
DANN
Benign
0.96
DEOGEN2
Benign
0.21
.;T;.;.;T;.
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.73
T;.;T;T;T;T
M_CAP
Pathogenic
0.30
D
MetaRNN
Benign
0.26
T;T;T;T;T;T
MetaSVM
Uncertain
-0.19
T
PhyloP100
3.5
PrimateAI
Benign
0.40
T
PROVEAN
Benign
0.61
.;N;.;N;N;D
REVEL
Benign
0.11
Sift
Benign
0.36
.;T;.;T;T;T
Sift4G
Benign
0.15
T;T;T;T;T;T
Polyphen
0.15, 0.63
.;B;.;.;P;.
Vest4
0.26
MutPred
0.41
.;.;Loss of catalytic residue at V535 (P = 0.0246);Loss of catalytic residue at V535 (P = 0.0246);.;.;
MVP
0.92
MPC
0.066
ClinPred
0.25
T
GERP RS
4.0
gMVP
0.15
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0011
dbscSNV1_RF
Benign
0.018
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770149373; hg19: chrX-32591962; API